Ophthalmic Comprehensive Reports

2018 Retinal Pharmaceuticals Report: A Global Market Analysis for 2017-2023, October, 2018

The newly published 2018 Retinal Pharmaceuticals Report combines estimates of the prevalence of retinal diseases, including age-related macular degeneration, diabetic retinopathy, retinal vein occlusion, and inherited retinal diseases, with treatment estimates and discussions of therapies under development. The report includes new extended sections on gene therapies (discussing 68 developmental therapies), stem cell therapies (profiling 23), and sustained drug-delivery devices (22 in number). 

Market Scope’s report on retinal pharmaceuticals profiles 11 new anti-VEGF compounds and 28 biosimilars that could take a piece of the market from leading products. 

Want to Purchase the Full Report?

Register A Corporate Account

A corporate accounts gives you access to licensed reports and subscriptions, the latest news, and a personalized dashboard.

Select one or more
Select one or more

Market Scope

13421 Manchester Road, Suite 201 | St. Louis, MO 63131 | Phone: 314-835-0600 | Email: info@market-scope.com

©2019 Market Scope, LLC. All Rights reserved.